Q2 FY27 results approved; board plans up to Rs 287.5 Cr debenture raise
CANHLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts less than Nifty Smallcap 250 and 1.4 pts less than its Life Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board on Oct 9, 2026 approved unaudited Q2 and H1 FY27 results (ended Sep 30, 2026). Joint auditors Brahmayya and Co. and M Bhaskara Rao and Co. gave a clean review with one emphasis note on the company deferring Ind AS by one year with IRDAI approval. Board also approved raising up to Rs 287.50 crore via subordinated non-convertible debentures on private placement. Q2 PAT grew to Rs 43.05 crore from Rs 40.81 crore YoY. H1 PAT stood at Rs 71.19 crore versus Rs 64.23 crore. Investment income turned negative in Q2 due to mark-to-market impact on equity in unit-linked funds.
Clean review, modest PAT growth. Capital raise to bolster solvency. Negative investment income in Q2 a watch point amid market volatility.